Evidence map›Paper›PMID 42799873›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Demographic and clinical differences between individuals with and without DXA scans in Denmark.

Sally Søgaard Andersen, Annika Vestergaard Kvist, Mia Daugaard Madsen, Peter Vestergaard, Rikke Viggers

Abstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sally Søgaard Andersen *Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. sally.andersen@rn.dk.ORCID http://orcid.org/0009-0004-8448-4424
Annika Vestergaard Kvist *Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
Mia Daugaard MadsenSteno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
Peter VestergaardSteno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
Rikke ViggersSteno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study utilized two Danish registry-based cohorts to compare characteristics of DXA scanned individuals with not DXA scanned individuals. DXA scanned individuals had more comorbidities and used more medications, but there were signs of insufficient DXA scanning, particularly regarding prior major fractures and systemic glucocorticoid use.

backgroundOsteoporosis is increasingly prevalent, yet many high-risk individuals remain undiagnosed and unscanned with dual-energy X-ray absorptiometry (DXA). We aimed to describe DXA use in Denmark, focusing on characteristics, comorbidities, and medication use among scanned versus non-scanned individuals, and to assess changes over time by comparing 2000-2010 with 2011-2021.

methodsWe conducted a nationwide cross-sectional study using two Danish registry-based cohorts: individuals with fractures and individuals with diabetes, each matched to controls without these conditions. Individuals aged ≥50 years with a first DXA scan between 2000 and 2021 were identified and compared with sex- and birth year-matched individuals without a recorded DXA scan regarding comorbidities, prior fractures, lifestyle-related risk proxies, and medication use. Descriptive statistics and standardized mean differences were used overall and across time periods.

resultsWe included 379,686 and 348,980 individuals with a recorded DXA and 1,571,452 and 1,736,828 individuals without a DXA from the two databases. DXA recipients were older, more often female, and had a greater burden of comorbidities, prior fractures, and use of centrally acting, cardiovascular, and anti-osteoporotic medications. These differences were more pronounced in 2011-2021. Nevertheless, a substantial proportion of individuals with major fractures or users of systemic glucocorticoids had never undergone DXA.

conclusionDXA utilization in Denmark increasingly targets individuals at high fracture risk, yet significant gaps persist in secondary fracture prevention. Improved identification and assessment of high-risk patients - particularly those with major fractures - remain essential.

Indexed as

DXAEpidemiologyFracturesOsteoporosis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.